Clinical pharmacokinetics of pancuronium bromide

[1]  Harold G. Boxenbaum,et al.  Statistical estimations in pharmacokinetics , 1974, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  P. J. Fell,et al.  Pharmacokinetics — Uses and abuses , 1975, European Journal of Clinical Pharmacology.

[3]  M. Dubois,et al.  Proceedings: Plasma concentrations of pancuronium bromide (pavulon) in patients with normal and impaired renal function. , 1975 .

[4]  W. Buzello.  [The metabolism of pancuronium in man]. , 1975, Der Anaesthesist.

[5]  D. Meijer,et al.  The Fate of Pancuronium Bromide in Man , 1973, Acta anaesthesiologica Scandinavica.

[6]  R. Miller,et al.  The Effect of Renal Failure and Hyperkalemia on the Duration of Pancuronium Neuromuscular Blockade in Man , 1973, Anesthesia and analgesia.

[7]  D. Meijer,et al.  Fluorimetric and chromatographic determination of pancuronium bromide and its metabolites in biological materials. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[8]  S. Kamvyssi-Dea,et al.  THE USE OF PANCURONIUM BROMIDE IN OPERATIONS FOR RENAL INSUFFICIENCY , 1972 .

[9]  M. Gibaldi,et al.  Kinetics of the Elimination and Neuromuscular Blocking Effect of d-Tubocurarine in Man , 1972, Anesthesiology.

[10]  M. Gibaldi,et al.  Tubocurarine and renal failure. , 1972, British journal of anaesthesia.

[11]  M. Gibaldi,et al.  Drug distribution and pharmacologic effects , 1971 .

[12]  R. Katz.  Comparison of Electrical and Mechanical Recording of Spontaneous and Evoked Muscle Activity: The Clinical Value of Continuous Recording as an Aid to the Rational Use of Muscle Relaxants During Anesthesia , 1965, Anesthesiology.